![logo](/logos/NEULANDLAB.NS.webp)
Neuland Laboratories Limited
NSE:NEULANDLAB.NS
12,904.85 (INR) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Neuland Laboratories Limited |
Symbool | NEULANDLAB.NS |
Munteenheid | INR |
Prijs | 12,904.8 |
Beurswaarde | 165,567,935,015 |
Dividendpercentage | 0.16% |
52-weken bereik | 3,400 - 13,221.7 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Davuluri Sucheth Rao |
Website | https://www.neulandlabs.com |
An error occurred while fetching data.
Over Neuland Laboratories Limited
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson. It also provides custom manufacturing solutions, as well as peptide
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)